延长抗生素预防在自体脂肪移植全乳房再造中的疗效:一项回顾性队列研究
该回顾性队列研究分析了2020年12月9日至2023年10月10日期间接受自体脂肪移植全乳房再造的205例患者共765次手术,比较围手术期联合术后抗生素预防(第1组)与仅围手术期预防(第2组)对手术部位感染的影响,发现延长抗生素预防无效,两组手术部位感染率无统计学显著差异。
要点
- 延长抗生素预防组与仅围手术期预防组手术部位感染风险无统计学显著差异,RR为0.68(95%CI 0.14-3.31)。
- 绝对风险降低为0.46%(95%CI -1.40至2.32),需治疗人数为219例患者。
- 作者结论认为延长抗生素预防对自体脂肪移植全乳房再造患者无效。
核心结论
- 延长抗生素预防对接受自体脂肪移植全乳房再造的患者无效,与单次围手术期抗生素预防相比,再造乳房手术部位感染无统计学显著差异。
研究设计与样本
- 回顾性队列研究,纳入2020年12月9日至2023年10月10日期间接受自体脂肪移植全乳房再造并在多次手术中接受抗生素预防的患者。
- 共分析205例患者的765次手术;第1组为168例患者的624次手术,接受围手术期联合术后抗生素预防;第2组为37例患者的141次手术,仅接受围手术期抗生素预防。
主要发现
- 与仅围手术期抗生素预防相比,接受围手术期联合术后抗生素预防的手术部位感染RR为0.68(95%CI 0.14-3.31)。
- 绝对风险降低为0.46%(95%CI -1.40至2.32),需治疗人数为219例患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat transfer (AFT) is increasingly adopted as another total breast reconstruction option. The aim of this study was to investigate the efficacy of prolonged antibiotic treatment on the onset of surgical site infections (SSIs) in patients treated with AFT for total breast reconstruction. METHODS: This retrospective cohort study was conducted on patients who received AFT for total breast reconstruction, with antibiotic prophylaxis during their (multiple) AFT procedure(s) from 9 December 2020 to 10 October 2023. Patients were divided into 2 groups according to their prophylactic antibiotic regimen. The primary outcome was analyzed, including the cumulative incidence, the relative risk (RR), the absolute risk reduction (ARR), and the number needed to treat (NNT). For the secondary outcome, a multilevel logistic regression analysis was performed. RESULTS: Seven hundred sixty-five surgeries in 205 patients were analyzed. Six hundred twenty-four surgeries on 168 patients had perioperative antibiotic prophylaxis in combination with postoperative antibiotic prophylaxis administered (group 1). One hundred forty-one surgeries on 37 patients had only perioperative antibiotic prophylaxis administered (group 2). The RR was 0.68 (95% confidence interval [CI]; 0.14-3.31) of a SSI when receiving peri- and postoperative antibiotic prophylaxis in comparison with treatment with only perioperative prophylaxis. The ARR was 0.46% (95% CI; -1.40 to 2.32) with a NNT of 219 patients. CONCLUSION: Prolonged antibiotic prophylaxis is ineffective for patients who receive total breast reconstruction with AFT. This study showed no statistically significant difference in SSIs of the reconstructed breast after receiving prolonged antibiotic treatment in comparison with single-shot perioperative antibiotic prophylaxis.
引用
- Rijkx MEP, Schiebroek EJM, Hommes JE, et al. The efficacy of prolonged antibiotic prophylaxis in total breast reconstruction with Autologous Fat Transfer (AFT): A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2024. PMID: 39168031. doi:10.1016/j.bjps.2024.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。